Enzon Pharmaceuticals (Bridgewater, NJ) says it plans to spin off its novel biotechnology business to create separate biotechnology and speciality pharmaceutical public companies. The transaction is expected to be completed in the fourth quarter. “The...
This information is only available to Chemical Week 24/7 members and subscribers.
Forgot your user ID or password? Click here to have it sent to you.
Not a Chemical Week
24/7 member yet? Here's why you
should be: Searchable online archive
access of the last 2 years
of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers